7 pending office actions • 3 clients
| Client (Assignee) | Pending OAs |
|---|---|
| Exuma Biotech Corp. | 4 |
| Cellphire, Inc. | 2 |
| BIOATLA, INC. | 1 |
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 18504080 | PLATELET DERIVATIVES FOR TREATING COAGULOPATHY | Cellphire, Inc. | UNDERDAHL, THANE E | 1699 | Non-Final OA | Nov 07, 2023 |
| 18335000 | METHODS AND COMPOSITIONS FOR TRANSDUCING AND EXPANDING LYMPHOCYTES AND REGULATING THE ACTIVITY THEREOF | Exuma Biotech Corp. | CARTER, SANDRA DILLAHUNT | 1674 | Non-Final OA | Jun 14, 2023 |
| 18297581 | PLATELETS LOADED WITH ANTI-CANCER AGENTS | Cellphire, Inc. | STAVROU, CONSTANTINA E | 1632 | Non-Final OA | Apr 07, 2023 |
| 17759242 | CHIMERIC ANTIGEN RECEPTORS TO HER2 AND METHODS OF USE THEREOF | BIOATLA, INC. | SKOKO III, JOHN JOSEPH | 1643 | Final Rejection | Jul 21, 2022 |
| 17684405 | METHODS AND COMPOSITIONS FOR THE DELIVERY OF MODIFIED LYMPHOCYTES AND/OR RETROVIRAL PARTICLES | Exuma Biotech Corp. | JOHNSON, ALLISON MARIE | 1638 | Non-Final OA | Mar 01, 2022 |
| 17639281 | METHODS AND COMPOSITIONS FOR THE MODIFICATION AND DELIVERY OF LYMPHOCYTES | Exuma Biotech Corp. | TINSLEY, BRENDAN THOMAS | 1634 | Non-Final OA | Feb 28, 2022 |
| 17272631 | METHODS AND COMPOSITIONS FOR GENETICALLY MODIFYING LYMPHOCYTES IN BLOOD OR IN ENRICHED PBMCS | Exuma Biotech Corp. | BURKHART, MICHAEL D | 1638 | Non-Final OA | Mar 01, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial